'A lot of opportunity in the conventional generics': Apotex CEO on rise of interest in generics – BNN Bloomberg

Skip to main content

ADVERTISEMENT

The Open

'A lot of opportunity in the conventional generics': Apotex CEO on rise of interest in generics

Jeff Watson, president and CEO of Apotex, joins BNN Bloomberg to discuss the company's next chapter and the pharma landscape in Canada.

June 16, 2026 at 10:32AM EDT

'We actually think autonomous vehicles are going to be a great enabler for Uber': MurrayOpens in new window

07:05 · June 17, 2026 at 10:21AM EDT

'Our view is more of a hawkish tilt': Goldberg on expectations for Kevin WarshOpens in new window

06:15 · June 17, 2026 at 10:11AM EDT

'We could actually have more supply than we did prior to the crisis': Aul on U.S.-Iran dealOpens in new window

09:59 · June 17, 2026 at 10:00AM EDT

'We've had growth in seven of the twelve major cities across Toronto': Cohen on luxury housing salesOpens in new window

07:24 · June 17, 2026 at 9:36AM EDT

'Would I buy it here? Probably not': Connell on SpaceXOpens in new window

07:35 · June 17, 2026 at 9:25AM EDT

What's driving the surge of investment across the mining sector?Opens in new window

05:59 · June 16, 2026 at 10:42AM EDT

'A lot of opportunity in the conventional generics': Apotex CEO on rise of interest in genericsOpens in new window

06:30 · June 16, 2026 at 10:32AM EDT

'We do expect another quarter of very solid earnings growth': SchleifOpens in new window

06:38 · June 16, 2026 at 10:19AM EDT

Oil at lowest level since early days of Iran conflictOpens in new window

08:49 · June 16, 2026 at 9:57AM EDT

'We've seen this movie before, we know how it ends': Orlando on U.S.-Iran negotiationsOpens in new window

07:23 · June 16, 2026 at 9:27AM EDT